Skip to main content
. 2015 Jan 22;6(7):4569–4584. doi: 10.18632/oncotarget.3174

Figure 4. Azithromycin inhibits tumor-sphere formation in eight other cell lines, derived from diverse cancer types.

Figure 4

Figure 4

For simplicity, the efficacy of azithromycin was tested at a concentration of 250 μM. (*)p <0.001. (A) ER(−) breast [MDA-MB-231] and ovarian cancer cell lines [SKOV3, ES2, Tov21G] (B) Lung [A>549], prostate [PC3], melanoma [A375], and pancreatic [MIA PaCa2].